| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Research and development | 5,549,101 | |||
| General and administrative | 4,042,544 | |||
| Total operating expenses | -9,591,645 | |||
| Loss from operations | -9,591,645 | |||
| Interest income | 124,828 | |||
| Interest expense | -149 | |||
| Other income (expense), net | 124,679 | |||
| Net loss | -9,466,966 | |||
| Earnings per share, basic | -0.63 | |||
| Earnings per share, diluted | -0.63 | |||
| Weighted average number of shares outstanding, basic and diluted | 15,116,548 | |||
| Weighted average number of shares outstanding, diluted | 15,116,548 | |||
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)